Pondo termo ao acesso não autorizado aos recursos genéticos (quer dizer, biopirataria): acesso aberto limitado 12/06/2018 by Intellectual Property Watch Leave a Comment O “acesso aos recursos genéticos” e a “participação justa e equitativa dos benefícios provenientes de sua utilização” vêm aturdindo delegados e delegações das 13 Conferências das Partes da Convenção das Nações Unidas sobre Diversidade Biológica, que entrou em vigor no ano de 1993. A expressão entre aspas conhecida pela sigla em inglês “ABS” é o terceiro objetivo do Convênio e se encontra entrelaçada pelos dois primeiros objetivos que são a conservação e o uso sustentável. Apesar de 25 anos de esforços e de uma bioeconomia de quase um trilhão de dólares, são muito poucos os contratos celebrados. Desses poucos, os benefícios monetários são tão baixos que as partes contratantes relutam em revelá-los. A “Lei brasileira de ABS” de 2015, que entrou em vigor no dia 6 de novembro de 2017 permite, por exemplo, a obtenção de royalties sobre vendas líquidas tão baixos que isso implica a celebração de contratos pela bagatela de uma décima parte de um por cento. Citando as palavras de um jurista erudito, os Usuários pagam “uma miséria pela biodiversidade”.
Health Policy Watch: Senior Reporter – Global Health Policy – Job Announcement 11/06/2018 by Intellectual Property Watch, Intellectual Property Watch Leave a Comment NOTE: POSITION CLOSED – Health Policy Watch, www.healthpolicy-watch.org, is seeking a dynamic journalist to lead our reporting on global health policy issues in Geneva and beyond. The writer will form part of a small, dynamic team committed to providing top-quality, independent, professional reporting to our audience.
Legislation For South Africa’s New IP Policy Likely After Elections Next Year 11/06/2018 by Linda Daniels for Intellectual Property Watch 1 Comment Legislative changes giving effect to South Africa’s recently published Intellectual Property Policy “Phase 1” will not take place during this term of government, the country’s trade minister has said. Meanwhile, a side-by-side comparison with the 2017 draft legislation shows a series of changes in the final policy, and the pharmaceutical industry is complaining but appears determined to continue investing in the country.
IP, AI, Health Commitments Mere Footnotes In Quarrel Between G6 And Trump? 11/06/2018 by Monika Ermert for Intellectual Property Watch 1 Comment Leaders at the G7 Summit tried to mitigate tensions by taking on some US favourites in their final communiqué like “forced technology transfers,” a topic brought up only recently by the United States at the World Trade Organisation. Forced technology transfers, according to US diplomats, are licensing and administrative rules entertained by China to oblige foreign firms to share technology in exchange for gaining access to the Chinese market. They also had sought to agree on a vision for artificial intelligence, a range of health issues, and foreign cyber interference with elections.
Opportunities, Risks Of Rapid Technological Change Discussed At UN 08/06/2018 by David Branigan, Intellectual Property Watch Leave a Comment The Third annual United Nations Multi-stakeholder Forum on Science, Technology and Innovation for the Sustainable Development Goals opened with Marie Chatardová, president of the Economic and Social Council, stating that “STI is shaping the trajectory of our society, helping the world address global challenges and achieve Sustainable Development Goals.”
US Section 301, China, And Technology Transfer: Law And Its Limitations Revisited (Again) 07/06/2018 by Intellectual Property Watch 3 Comments Frederick Abbott writes: On 20 May 2018, US Treasury Secretary Mnuchin announced that the US and China were “putting the trade war on hold” while the two countries seek to “execute the framework” of a broad agreement intended to reduce the US trade deficit in goods with China. According to the joint statement issued on 19 May 2018, “Both sides attach paramount importance to intellectual property protections, and agreed to strengthen cooperation. China will advance relevant amendments to its laws and regulations in this area, including the Patent Law.”
TRIPS Council Debates IP Improving Lives, Competition Law To Increase Medicines Access 07/06/2018 by Catherine Saez, Intellectual Property Watch 1 Comment Whether intellectual property rights are improving lives or whether they should be reined in by tools such as competition law to increase access to medicine, education, and innovation, was debated this week at the World Trade Organization committee on intellectual property. Also on the agenda was a suggestion by least-developed countries to create incentives for developed country companies and institutions to transfer technologies for the benefit of the poorest countries.
EU Files WTO Case Against China Over IP Rights Protection 06/06/2018 by William New, Intellectual Property Watch 2 Comments The European Union has filed a World Trade Organization dispute settlement complaint against China for unfair treatment of foreign intellectual property rights holders. The case follows a similar filing by the United States against China.
EUIPO Study Looks At State Of IPR Infringement In The EU 06/06/2018 by Monika Ermert for Intellectual Property Watch Leave a Comment A report published today by the EU Intellectual Property Office (EUIPO) deplores rising volume of intellectual property rights infringement in both immaterial goods and digital content and warns against the economic effects for the Union.
Experts In Geneva: Substandard, Falsified Medicines Not About IP 06/06/2018 by Catherine Saez, Intellectual Property Watch 1 Comment Falsified and substandard medical products continue to be a global concern, and how those products are characterised is important to avoid confusion, particularly with intellectual property rights infringement. A panel convened by Brazil, India and South Africa yesterday at the World Trade Organization looked at the implications of a new definition of such products at the neighbouring World Health Organization.